Literature DB >> 15754187

[Errors and risks in perioperative thrombolysis therapy].

F Spöhr1, B W Böttiger, A Walther.   

Abstract

Until recently, perioperative thrombolysis has always been thought to be a contraindication, because of the risk of bleeding complications. However, many case reports now show that thrombolytic drugs can be successfully used in the perioperative period. Possible indications for perioperative thrombolysis are massive pulmonary embolism and cardiopulmonary resuscitation which are also important causes of cardiac arrest. Thrombolysis can be the decisive therapeutical option, e.g. when normal cardiopulmonary resuscitation measures are not successful. Nevertheless, even against the background of many positive case reports the indication for perioperative thrombolysis should be a case-specific decision as the frequency of complications depends on the surgical intervention and must be weighed against the possible benefits of early thrombolysis. For perioperative thrombolysis there are no data available showing a beneficial effect of one particular therapeutic regimen. In the literature it is suggested that thrombolysis should be performed as quickly as possible, because the risk of bleeding complications depends more on the duration of thrombolysis than on the dosage or the thrombolytic drug itself.

Entities:  

Mesh:

Year:  2005        PMID: 15754187     DOI: 10.1007/s00101-005-0828-z

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  75 in total

1.  Effective administration of recombinant tissue plasminogen activator (rt-PA) during resuscitation of a post partum patient with massive pulmonary embolism.

Authors:  A Cyrkowicz; M Bajorek; J Nytko; W Solarz; W Weryński; K Orczyk
Journal:  Zentralbl Gynakol       Date:  1999

2.  Successful thrombolysis for massive pulmonary embolism after pulmonary resection.

Authors:  R A Sayeed; S A Nashef
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

3.  [Lysis therapy with rt-PA in fulminant pulmonary embolism].

Authors:  J Popp; R Geiger
Journal:  Dtsch Med Wochenschr       Date:  1990-06-15       Impact factor: 0.628

Review 4.  [Fibrinolysis and thrombolytic drugs].

Authors:  E Seifried
Journal:  Internist (Berl)       Date:  1992-04       Impact factor: 0.743

5.  Survival from catastrophic intraoperative pulmonary embolism.

Authors:  G H Pharo; A Andonakakis; K Chandrasekaren; G Amron; J D Levitt
Journal:  Anesth Analg       Date:  1995-07       Impact factor: 5.108

Review 6.  Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism.

Authors:  B W Böttiger; H Böhrer; A Bach; J Motsch; E Martin
Journal:  Resuscitation       Date:  1994-07       Impact factor: 5.262

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

8.  High-dose bolus injection of urokinase. Use during cardiopulmonary resuscitation for massive pulmonary embolism.

Authors:  B W Böttiger; S M Reim; G Diezel; H Böhrer; E Martin
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

9.  Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.

Authors:  S Z Goldhaber; C M Kessler; J Heit; J Markis; G V Sharma; D Dawley; J S Nagel; M Meyerovitz; D Kim; D E Vaughan
Journal:  Lancet       Date:  1988-08-06       Impact factor: 79.321

10.  Acute pulmonary embolism treated with tissue plasminogen activator.

Authors:  S Z Goldhaber; D E Vaughan; J E Markis; A P Selwyn; M F Meyerovitz; J Loscalzo; D S Kim; C M Kessler; D L Dawley; G V Sharma
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

View more
  3 in total

1.  [Coagulation monitoring of lung embolism using thrombelastography. Resuscitation--Thrombolysis--Massive haemorrhaging].

Authors:  T Strasser; E Pscheidl
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

2.  [Successful thrombolysis of a massive pulmonary embolism following pneumonectomy].

Authors:  M Scheffler; T Menges; C Zörb; J Sucké; G Hempelmann
Journal:  Anaesthesist       Date:  2008-04       Impact factor: 1.041

3.  Unexpected complication of massive intraoperative pulmonary embolism following elective sigmoidectomy in the supine position.

Authors:  Ekaterini N Amaniti; Georgia G Tsaousi; Nektarios A Kteniadakis; Panagiota G Maidatsi; Dimitrios G Vasilakos
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.